Search research articles
Contact Us
Filters
Showing results (161-170 of 347) with videos related to
Page
of 35
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 24, 2021
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
Lin Gui, Junning Cao, Dongmei Ji, et al.
Journal of Hematology & Oncology
|
May 3, 2023
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization
Chen Chen, Liyuan Dai, Cuiling Zheng, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 24, 2026
Anlotinib Plus Sintilimab for <i>BRAF<sup>V600E</sup></i> Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial
Lin Gui, Haohua Zhu, Le Tang, et al.
European Journal of Haematology
|
June 9, 2023
Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients
Yan Qin, Xiaohui He, Xinrui Chen, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 23, 2021
Dismal outcome of relapsed or primary refractory adult T-cell lymphoblastic lymphoma: A retrospective study from China
Haizhu Chen, Yan Qin, Jianliang Yang, et al.
Targeted Oncology
|
March 25, 2019
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study
Xiaonan Hong, Yuqin Song, Huiqiang Huang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 10, 2009
Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib
Fei Ma, Tong Sun, Yuankai Shi, et al.
Cancer Chemotherapy and Pharmacology
|
July 19, 2014
Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
Jianliang Yang, Yuankai Shi, Chunlei Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 9, 2015
[Risk factors for Clostridium difficile-associated diarrhea among cancer patients]
Yu Zhu, Li Wang, Shana Feng, et al.
Leukemia & Lymphoma
|
July 23, 2021
Low platelet/platelet distribution width and high platelet/lymphocyte ratio are adverse prognostic factors in patients with newly diagnosed advanced Hodgkin lymphoma
Yunxia Tao, Xiaohui He, Yan Qin, et al.
Page
of 35
Search research articles
Search
Showing results (161-170 of 347) with videos related to
Sort By:
Page
of 35
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
November 24, 2021
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
Lin Gui, Junning Cao, Dongmei Ji, et al.
Journal of Hematology & Oncology
|
May 3, 2023
Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization
Chen Chen, Liyuan Dai, Cuiling Zheng, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 24, 2026
Anlotinib Plus Sintilimab for <i>BRAF<sup>V600E</sup></i> Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial
Lin Gui, Haohua Zhu, Le Tang, et al.
European Journal of Haematology
|
June 9, 2023
Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients
Yan Qin, Xiaohui He, Xinrui Chen, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 23, 2021
Dismal outcome of relapsed or primary refractory adult T-cell lymphoblastic lymphoma: A retrospective study from China
Haizhu Chen, Yan Qin, Jianliang Yang, et al.
Targeted Oncology
|
March 25, 2019
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study
Xiaonan Hong, Yuqin Song, Huiqiang Huang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 10, 2009
Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib
Fei Ma, Tong Sun, Yuankai Shi, et al.
Cancer Chemotherapy and Pharmacology
|
July 19, 2014
Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
Jianliang Yang, Yuankai Shi, Chunlei Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 9, 2015
[Risk factors for Clostridium difficile-associated diarrhea among cancer patients]
Yu Zhu, Li Wang, Shana Feng, et al.
Leukemia & Lymphoma
|
July 23, 2021
Low platelet/platelet distribution width and high platelet/lymphocyte ratio are adverse prognostic factors in patients with newly diagnosed advanced Hodgkin lymphoma
Yunxia Tao, Xiaohui He, Yan Qin, et al.
Page
of 35